Esteban Urias

Appearances

DIFFERENTIAL EFFECTS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS ON LIVER PHENOTYPES BASED ON <i>PNPLA3</i> GENOTYPE
Date
May 8, 2023
BACKGROUND: The glucagon-like-receptor (GLP)-1 agonist semaglutide has demonstrated therapeutic efficacy on clinical endpoints in a recent phase 2 clinical trial in patients with non-alcoholic steatohepatitis (NASH)(Newsome et al. NEJM, 2021)…
Presenter
Esteban Urias
Speakers
Chinmay Raut
Antonino Oliveri
Kristin Krach
Elizabeth Speliotes
Vincent Chen
University of Michigan Medical School
FIBROSCAN-ASPARTATE AMINOTRANSFERASE SCORE PREDICTS RISK OF LIVER-RELATED EVENTS IN NON-ALCOHOLIC FATTY LIVER DISEASE
Date
May 6, 2023
The rising prevalence of non-alcoholic fatty liver disease (NAFLD) will result in increased referrals to gastroenterology and hepatology units…
Presenter
Michael Song
Speakers
Nicole Xinrong Han
Tanvi Goyal
Wei Xuan Tay
Esteban Urias
Karn Wijarnpreecha
Yu Jun Wong
Vincent Chen
University of Michigan Medical School